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Abstract
It is well documented that reactive oxygen species (ROS) affects neurodegeneration in the brain. Several studies also
implicate ROS in the regulation of synapse function and learning and memory processes, although the precise source
of ROS generation within these contexts remains to be further explored. Here we show that postsynaptic superoxide
generation through PKCζ-activated NADPH oxidase 2 (NOX2) is critical for long-term depression (LTD) of synaptic
transmission in the CA1–Shaffer collateral synapse of the rat hippocampus. Speciﬁcally, PKCζ-dependent
phosphorylation of p47phox at serine 316, a NOX2 regulatory subunit, is required for LTD but is not necessary for long-
term potentiation (LTP). Our data suggest that postsynaptic p47phox phosphorylation at serine 316 is a key upstream
determinant for LTD and synapse weakening.
Introduction
Synapse weakening is part of a group of physiological
processes referred to as synaptic plasticity, which govern
changes in synaptic function in response to neuronal
activity, and are thought to represent the cellular and
molecular mechanisms of learning and memory1. On the
other hand, aberrant activation of synapse weakening
signalling pathways has been reported in several Alzhei-
mer’s disease (AD) models2–4, suggesting that these sig-
nalling pathways represent a crucial interplay between
physiology and the onset of disease-associated patho-
physiology. Mounting evidence suggests that apoptotic
signalling cascades, including caspase-3 and glycogen
synthase kinase 3β (GSK-3β) activation, are centrally
involved in physiological and pathophysiological forms
of synapse weakening, manifest through postsynaptic
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
receptor (AMPAR) endocytosis and long-term depression
(LTD) of synaptic transmission4–6. However, how these
signals are ﬁrst initiated is unknown.
Reactive oxygen species (ROS) are not only well-known
upstream regulators of neuronal apoptosis7 and neuro-
degenerative signals8 but are also known to play
important regulatory roles in aspects of neuronal phy-
siology, including synaptic plasticity and synapse weak-
ening9–13. ROS can originate from numerous sources to
affect synaptic plasticity, including presynaptic neurons,
postsynaptic neurons and microglia11, 13. However, to
date there has been no characterization or elucidation
of the precise mechanisms of ROS generation that
regulate synaptic plasticity.
Here, we examined the production of postsynaptic ROS
during LTD, revealing a key role for postsynaptic ROS
production via NADPH oxidase 2 (NOX2). Crucially, we
ﬁnd that the activity of postsynaptic protein kinase C zeta
(PKCζ) is also required for LTD and identify the
phosphorylation of p47phox at serine 316 as a necessary
step in this pathway. Therefore, our results uncover a role
for a speciﬁc postsynaptic ROS production pathway in
activity-dependent synapse weakening.
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Results
Postsynaptic superoxide is required for LTD in the CA1 of
the hippocampus
Superoxide ions are one of the primary forms of ROS and
are known to be elevated in neurons following the activation
of N-methyl-D-aspartate receptors (NMDARs)14–16. We
therefore hypothesized that intra-neuronal superoxide
radicals are upstream regulators of NMDAR-dependent
forms of synaptic plasticity. To address this, we analysed the
effects of superoxide dismutase (SOD), a class of endogen-
ous enzymes that catalyse superoxide dismutation17, on an
NMDAR-dependent form of LTD in rat hippocampal acute
slices18. Accordingly, whilst application of low-frequency
electric stimulation (LFS) during whole-cell patch clamp
recording readily induced LTD in CA1–Schaffer collateral
synapses (52.8 ± 9.0% of baseline, p= 0.002 vs. control
input, Fig. 1a), postsynaptic infusion of SOD (300 units/ml)
through the patch pipette blocked LTD (89.5 ± 8.7% of
baseline, p= 0.115 vs. control input, Fig. 1b). To determine
whether the superoxide radicals involved in this form of
LTD could originate from an extracellular source, such as
microglia13, we bath applied SOD. Given that SOD has poor
membrane permeability19, extracellular bath application of
the enzyme will catalyse extracellular superoxide dismuta-
tion without affecting intracellularly generated superoxide.
Extracellular SOD application had no effect on LTD (57.5 ±
9.9% of baseline, p= 0.004 vs. control input, Fig. 1c), sug-
gesting that postsynaptic intracellular superoxide, speciﬁ-
cally, is critical for LTD expression. Since hydrogen peroxide
(H2O2), another ROS, can be a product of SOD catalysis of
superoxide dismutation and is also implicated in synaptic
plasticity20, we tested whether H2O2 is required for LTD.
Postsynaptic infusion of catalase (300 units/ml), an enzyme
that catalyses the decomposition of H2O2 to water and
oxygen, had no effect on LTD (66.8 ± 4.7% of baseline, p=
0.002 vs. control input, Fig. 1d). We also tested whether
H2O2 may be inhibiting NMDAR-LTD, which could pro-
vide an alternative explanation for the inhibition of LTD
induced by SOD injection. To test this, we postsynaptically
injected SOD along with catalase, thereby scavenging the
H2O2 product of the SOD reaction. In this experiment, LTD
was also blocked (SOD+catalase, 90.1 ± 4.8% of baseline, p
= 0.150 vs. baseline, Fig. 1e). In bath application experi-
ments, SOD and catalase co-treatment did not affect LTD
(SOD+catalase, 68.3 ± 1.2% of baseline, p < 0.001 vs. base-
line, Fig. 1f). Together, these results suggest that post-
synaptic intracellular superoxide is required for NMDAR-
dependent hippocampal LTD and that H2O2 itself is neither
required for nor an inhibitor of LTD.
NOX2 regulates LTD
While several ROS-inducing mechanisms are present in
neurons, emerging evidence suggests that superoxide
production post-NMDAR activation is catalysed by
NADPH oxidase (NOX)15, 16. NOX is a membrane-bound
enzymatic complex responsible for the production of ROS
and is present in neurons where it can localize to
synapses21. Speciﬁcally, NOX2, commonly known as the
prototypical NOX, has been suggested as the primary
regulator of NMDAR-activated superoxide generation15.
While NOX1–4 are reported to be expressed in the brain,
NOX3 constitutively generates superoxide without sti-
mulation22 and NOX4 constitutively produces H2O2
23, an
ROS that appears not to be involved in LTD. We there-
fore predicted that postsynaptic NOX1 and 2 are the most
likely candidates for superoxide production during LTD.
To test a requirement for these NOX isoforms for LTD,
we utilized postsynaptic infusion of NOX inhibitors.
Postsynaptic infusion of AEBSF (20 µM), a non-selective
inhibitor of NOX24, blocked LTD expression in CA1
neurons of acute hippocampal slices (90.4 ± 6.0% of
baseline, p= 0.146 vs. control input, Fig. 2a), whilst
postsynaptic infusion of the speciﬁc NOX1 inhibitor ML-
171 (3 μM)25 had no effect on LTD (58.9 ± 8.6% of base-
line, p= 0.006 vs. control input, Fig. 2b). Postsynaptic
infusion of apocynin (100 µM), a putative but non-
selective inhibitor of NOX226, signiﬁcantly impaired
LTD expression (88.7 ± 8.3% of baseline, p= 0.583 vs.
control input, Fig. 2c). In contrast, bath perfusion of
apocynin after LTD induction failed to reverse the
expression of LTD, indicating that NOX2 is not required
for LTD maintenance (apocynin perfusion: 68.8 ± 4.0% of
baseline vs. control: 78.9 ± 3.4% of baseline, p= 0.078,
Supplementary Fig. S1). Together, these data are sugges-
tive of a speciﬁc role for the NOX2 isoform of NOX in the
regulation of LTD induction.
Owing to the limited pharmacological selectivity and
off-target effects of available NOX inhibitors, we next
utilized short hairpin RNA (shRNA) to knockdown either
NOX1 or 2 expression (Fig. 2d). Biolistic transfection of
NOX1 or NOX2 shRNA into CA1 neurons of organotypic
cultured hippocampal slices was performed. LTD was
readily inducible in cells transfected with NOX1 shRNA
(NOX1 shRNA: 54.9 ± 4.7% of baseline; untransfected
cells: 61.7 ± 3.5% of baseline, p= 0.280, Fig. 2e). In con-
trast, LTD was abolished in neurons transfected with
NOX2 shRNA (NOX2 shRNA: 87.3 ± 11.5% of baseline;
untransfected cells: 50.7 ± 7.4% of baseline, p= 0.028,
Fig. 2f). Neither NOX1 nor NOX2 shRNA inﬂuenced
the basal state of glutamatergic synaptic transmission, as
measured by AMPAR-mediated excitatory postsynaptic
current (EPSCAMPA; Supplementary Fig. S2a and S2c) and
NMDAR-mediated EPSC (EPSCNMDA; Supplementary
Fig. S2b and S2d). Furthermore, transfection of a scram-
bled form of NOX2 shRNA had no effect on LTD
(scrNOX2 shRNA: 54.9 ± 7.3% of baseline; untransfected
cells: 49.3 ± 5.2% of baseline, p= 0.541, Supplementary
Fig. S2e). Therefore, our data strongly suggest that ROS
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production through postsynaptic NOX2 is involved in
LTD regulation.
PKCζ and phosphorylation of p47phox is required for LTD
The function of NOX1/NOX2 is principally regulated
through multi-site phosphorylation of the p47phox sub-
unit of the complex by PKC isoforms, including the aty-
pical PKCζ27, 28. Given the requirement for NOX2 in
LTD, we hypothesized that phosphorylation of p47phox
would also be required. To test this, we ﬁrst utilized
biolistic transfection of p47phox shRNA in CA1 neurons
of organotypic hippocampal slices to knock down the
expression of p47phox (Supplementary Fig. S3). Trans-
fection of p47phox shRNA had no signiﬁcant effect
on basal EPSCAMPA compared with untransfected neigh-
bouring cells (untransfected: 145.0 ± 15.1 pA, transfected:
162.1 ± 15.1 pA, p= 0.594, Fig. 3a). Consistent with our
hypothesis, p47phox shRNA transfection signiﬁcantly
impaired LTD expression when compared to untrans-
fected cells (p47phox shRNA-transfected cells: 87.2 ±
11.5% of baseline; untransfected cells: 50.6 ± 7.1% of
baseline, p= 0.0145, Fig. 3b).
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Fig. 1 Postsynaptic superoxide is required for LTD expression. a Low frequency stimulation (LFS) induces LTD in patch clamp recording mode in
CA1–Schaffer collateral synapses in rat hippocampal acute slices (n= 6). b Postsynaptic injection of SOD (300 units/ml) blocked LTD (n= 5). c Bath
application of SOD has no effect on LTD expression (n= 5). d Postsynaptic infusion of catalase (300 units/ml, 20 min) has no effect on LTD (n= 5).
e Postsynaptic infusion of SOD and catalase inhibits LTD (n= 6). f Bath perfusion of SOD and catalase has no effect on LTD (n= 6). Symbols and error
bars indicate mean ± SEM
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Since phosphorylation of the p47phox subunit by the
atypical PKCζ leads to superoxide generation16, 27, we
therefore used PKCζ shRNA (Supplementary Fig. S4) to
examine whether PKCζ is also required for LTD. We
found that transfection of PKCζ shRNA had no signiﬁcant
effect on basal EPSCAMPA (untransfected: 241.0 ± 33.2 pA,
transfected 238.9 ± 22.6 pA, p= 0.957, Fig. 3c) but sig-
niﬁcantly impaired LTD (PKCζ shRNA: 90.6 ± 4.4% of
baseline; untransfected cells: 50.4 ± 5.4% of baseline, p=
0.0001, Fig. 3d). Furthermore, the p47phox shRNA-
mediated LTD deﬁcit was rescued by co-expression of
human p47phox (untransfected cells: 74.8 ± 8.9% of
baseline; transfected cells: 69.2 ± 4.5% of baseline, p=
0.583; Fig. 3e).
To substantiate our hypothesis that PKCζ is an active
component of LTD signalling, we tested whether LFS of
hippocampal slices, which leads to NMDAR activation
and LTD induction, regulates PKCζ activity. To do this,
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Fig. 2 Neuronal NADPH oxidase 2 (NOX2) is required for LTD expression. a Postsynaptic infusion of the NADPH oxidase inhibitor AEBSF (20 μM)
blocks LTD (n= 5) in CA1 neurons from acute hippocampal slices. b Postsynaptic infusion of the NOX1 inhibitor ML-171 (3 μM) has no effect on LTD
(n= 5). c Postsynaptic infusion of the NOX2 inhibitor apocynin (100 μM) blocks LTD (n= 6). d Single-cell PCR assays demonstrate efﬁcient
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we utilized acutely prepared hippocampal slices prepared
from 3-week-old rats. Since PKCζ activity depends on the
phosphorylation of threonine 410 (pT410)29, 30, we ana-
lysed whether LFS phosphorylates PKCζ at pT410. We
found that LFS of Schaffer collateral afferents signiﬁcantly
increased phosphorylation of PKCζ at pT410, indicative of
PKCζ activation, and this was blocked by AP5 (50 μM), an
NMDAR antagonist (Control: 100 ± 16%; LFS: 185 ± 25%,
p < 0.05 compared to control; LFS+AP5: 123 ± 21%, p <
0.05 compared to LFS; AP5: 111 ± 21%, Fig. 3f).
Interestingly, long-term potentiation (LTP) was readily
inducible in cells expressing p47phox shRNA (p47phox
shRNA: 154.2 ± 6.5% of baseline; untransfected cells:
167.1 ± 14.9% of baseline, p= 0.416, Fig. 3g). LTP was also
intact in cells expressing PKCζ shRNA (PKCζ shRNA:
147.9 ± 9.4% of baseline; untransfected cells: 160.1 ± 10.0%
of baseline, p= 0.391, Fig. 3h), indicating a selective role
for p47phox and PKCζ in the LTD form of synaptic
plasticity. Together, these data indicate that PKCζ acti-
vation downstream of NMDAR activation is a funda-
mental component of LTD signalling, regulating the
activity of NOX2 via p47phox.
Phosphorylation of p47phox at serine 316 is required for
LTD
Since both p47phox shRNA and PKCζ shRNA trans-
fection resulted in a loss of LTD, it was of interest to
determine the speciﬁc molecular mechanism surrounding
the regulation of p47phox by PKCζ. We generated
shRNA-resistant constructs of rat p47phox with differing
combinations of site-speciﬁc mutations at four residues
phosphorylated by PKCζ27. Consistent with our working
hypothesis, LTD was blocked in cells co-transfected with
p47phox shRNA and an shRNA-resistant mutant form of
p47phox with all four residues mutated to alanine, to
prevent their phosphorylation (after LFS: 95.1 ± 6.8%, p=
0.725 vs. control input, Fig. 4a). In cells expressing a triple
phosphorylation mutant (S/T304/305/316A—residues
notated as per rat p47phox), LTD was also impaired
(after LFS: 88.0 ± 5.5%, p= 0.087 vs. control input,
Fig. 4b). In comparison, LTD was readily inducible in cells
transfected with a double S/T304/305A mutant (after
LFS: 57.2 ± 4.1%, p= 0.000117 vs. control input, Fig. 4c).
Notably, we found that LTD was also impaired in cells
expressing the S316A mutant form of p47phox (after LFS:
98 ± 22.8%, p= 0.73 vs. control input, Fig. 4d) but the
expression of S329A mutant form of p47phox had no
effect on LTD induction (after LFS: 63.1 ± 7.0%, p= 0.004
vs. control input, Fig. 4e). Finally, we tested whether
phosphorylation of p47phox at S316 is sufﬁcient to induce
synapse weakening, through paired recordings from
neurons transfected with a S316 pseudo-phosphorylated
form of p47phox (S316D) and neighbouring untrans-
fected neurons. Our data showed signiﬁcantly reduced
AMPAR-mediated currents in S316D-transfected neurons
(untransfected: 132.4 ± 12.9 pA vs. S316D transfected:
94.1 ± 9.4 pA, p= 0.023, Fig. 4f), indicating that phos-
phorylation at this residue is sufﬁcient to reduce AMPAR-
mediated synaptic transmission. This effect appears spe-
ciﬁc to AMPARs, as NMDAR-mediated currents were
unchanged between the two cell types (untransfected:
131.1 ± 11.7 pA vs. S316D transfected: 118.7 ± 13.7 pA,
p= 0.495, Fig. 4f). Taken together, these data suggest that
phosphorylation at S316 of p47phox, likely by PKCζ, is a
key regulator of a signalling cascade that governs LTD
induction and synapse weakening.
Discussion
The notion that ROS production is a key element of
synaptic plasticity has been well established11–13, 20, 31.
However, the precise source of ROS and mechanisms by
which it is regulated during synaptic plasticity have not
been fully elucidated. Identiﬁcation of these speciﬁc
signalling pathways is necessary for our full understanding
of its physiological and pathophysiological implications
in synaptic function.
In the present study, we have shown that postsynaptic
NOX2-mediated superoxide production, via PKCζ-
mediated phosphorylation of p47phox at the serine 316
residue (pS316 p47phox), is pivotal for LTD expression
and weakening of AMPAR-mediated synaptic transmis-
sion. Importantly, few studies have directly addressed the
(see ﬁgure on previous page)
Fig. 3 P47phox and PKCζ are necessary for LTD. a Synaptic AMPAR-mediated currents (EPSCAMPA) are unchanged between p47phox shRNA-
transfected cells and neighbouring untransfected cells (n= 13 pairs). Individual data points represent individual pairs of neurons. Red circles
represent mean ± SEM. b LTD is abolished in neurons transfected with p47phox shRNA (ﬁlled circle, n= 9), whilst LTD is induced in untransfected
cells (open circle, n= 8). c Synaptic AMPAR-mediated currents (EPSCAMPA) are unchanged between PKCζ shRNA-transfected cells and neighbouring
untransfected cells (n= 16 pairs). Individual data points represent individual pairs of neurons. Red circles represent mean ± SEM. d LTD is abolished in
neurons transfected with PKCζ shRNA (ﬁlled circle, n= 7), whilst LTD is induced in untransfected cells (open circle, n= 6). e Co-transfection of human
p47phox with p47phox shRNA rescues the expression of LTD (ﬁlled circles, n= 7) to levels similar to untransfected cells (open circles, n= 7).
f Immunoblots showing LFS-induced enhanced PKCζ phosphorylation at threonine 410 residue (pT410PKCζ; n= 5) and AP5 inhibition of LFS-
induced pT410PKCζ (n= 5). g LTP was present in p47phox shRNA-transfected cells (ﬁlled circle, n= 7) and untransfected cells (open circle, n= 5).
h LTP was readily induced in both PKCζ shRNA-transfected cells (ﬁlled circle, n= 7) and untransfected cells (open circle, n= 7). Data represents mean
± SEM. Asterisk (*) indicates statistical signiﬁcance (p < 0.05)
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source of ROS in the context of synaptic plasticity. Using
our selective knockdown approach, in which we have
speciﬁcally silenced or inhibited postsynaptic ROS pro-
duction, we have now shown that postsynaptic NOX2 is a
necessary hub for ROS production associated with LTD.
Several research groups have shown a similar requirement
for ROS during LTD or synapse weakening9, 10, 12, 13
whilst evidence from other groups suggests that ROS can
regulate LTP12, 31, 32. Quite how or why ROS can regulate
both forms of synaptic plasticity is unclear, but it is
possible that different ROS production sources and
mechanisms may underpin different forms of synaptic
plasticity.
NMDAR activation leads to PKCζ-mediated phosphor-
ylation of the p47phox subunit, which is a critical acti-
vator signal for NOX2 mediated ROS production15, 16. In
the present study, we show that low-frequency electrical
stimulation of hippocampal slices, which induces an
NMDAR-dependent form of LTD, also leads to the acti-
vation of PKCζ. This effect was blocked by D-AP5,
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indicative of synaptic NMDAR-dependent activation of
PKCζ that is associated with LTD induction. Importantly,
through postsynaptic knockdown of PKCζ expression, we
reveal an LTD-speciﬁc requirement for PKCζ with no
observable contribution to LTP expression, consistent
with other synapse weakening signals shown in previous
studies5, 6, 33–36. Finally, our data show that constitutive
phosphorylation of the PKCζ substrate, p47phox, at S316
is sufﬁcient to induce weakening of AMPAR-mediated
synaptic transmission, even in the absence of upstream
activator signals. This single phosphorylation event, which
induces NOX2 activation and ROS production, is there-
fore both necessary and sufﬁcient for synapse weakening.
It is not clear how postsynaptic ROS production is itself
involved in the mechanisms of LTD signalling. One pos-
sibility is that postsynaptic ROS activates Bax protein to
stimulate cytochrome c release from mitochondria37.
Cytochrome c release induces caspase-3 activation38,
which in turn can affect synapse weakening signal cas-
cades involving Akt-1 and GSK-3β4, 39. This possibility is
supported by the observation that Bax is itself required for
LTD signalling33.
A growing list of molecules, including caspases, GSK-3β
and tau, are now known to be involved in AMPAR
endocytosis and LTD5, 6, 33, 34. Collectively, these
molecules form what we have termed the synapse
weakening pathway, encompassing molecules associated
with apoptosis and synapse elimination in both
physiological and pathophysiological circumstances4, 36,
40. It has been postulated that the balance between
synapse weakening (caspase-3, GSK-3β and tau) and
strengthening pathways (phosphoinositide-3 kinase and
Akt-1) is critical to determine the direction of LTP
and LTD and long-term fate of synapses4–6, 35.
Indeed, models of neurodegenerative pathologies
such as AD exhibit AMPAR endocytosis and facilitated
LTD induction, concomitant with the inhibition of
LTP in the hippocampus2, 3, 39, 41, 42. Aberrant activation
of synapse weakening signals is therefore believed to be
a central underlying molecular mechanism in the
pathology and cognitive decline of numerous neurode-
generative diseases4, 40, 43, 44. Our results suggest that
ROS, via a speciﬁc production mechanism, now form
a part of this critical synapse weakening signalling cas-
cade. Addressing whether aberrant LTD-like and/or
AMPAR-mediated synapse weakening can be seen in
human forms of neurodegenerative disease remains a key
challenge to translating these ﬁndings into viable ther-
apeutic targets.
Materials and methods
Animals
All procedures involving animals were carried out in
accordance with the UK Animals (Scientiﬁc Procedures)
Act, 1986. Male Wistar rats (Charles River, UK) were used
to prepare organotypic (6–8 day-old rats) and acute hip-
pocampal slices (2–4-week-old rats). Older rats were
housed four or ﬁve per cage and allowed access to water
and food ad libitum. The cages were maintained at a
constant temperature (23 ± 1 °C) and relative humidity
(60 ± 10%) under a 12-h light/dark cycle (lights on from
07:30 to 19:30).
Acute hippocampal slices
Rats were killed by cervical dislocation and decapitation.
Following this, the brain was rapidly removed and placed
into ice-cold artiﬁcial cerebrospinal ﬂuid (aCSF; con-
tinuously bubbled with 95% O2/5% CO2) containing 124
mM NaCl, 3 mM KCl, 26 mM NaHCO3, 1.25 mM
NaH2PO4, 2 mM CaCl2, 1 mM MgSO4, and 10 mM D-
glucose. Hippocampi were extracted and transverse hip-
pocampal slices (400 µm thickness) were cut using a
McIlwain tissue chopper. Following manual separation,
the slices were then submerged in aCSF for a minimum of
1 h before experiments commenced.
Acute slices were placed in a recording chamber
and perfused with warmed (28–29 °C) and carbogenated
aCSF at 2ml/min. Two independent stimulating electrodes
were placed separately in the Schaffer collateral–CA1
input (test pathway) and subiculum–CA1 input (control
pathway). For whole-cell patch experiments, 20 μM
picrotoxin was included in the aCSF and CA1 neurons
were blind-patched using a 4–6MΩ borosilicate glass
pipette containing 130mM CsMeSO4, 8mM NaCl, 4mM
Mg-ATP, 0.3mMNa-GTP, 0.5mM EGTA, 10mMHEPES,
6mM QX-314, pH 7.2–7.3 and 280–290mOsm/kg.
For ﬁeld excitatory postsynaptic potential (fEPSP) record-
ings, a glass pipette containing 3M NaCl was placed in
the stratum radiatum region of the CA1. LTD experiments
during whole-cell patch were carried out as for cultured
hippocampal slices (see below), except a 20-min baseline
was used. For LTD of fEPSPs, a 30-min stable baseline at
70% of maximum stimulation intensity was followed by
LFS, consisting of 900 pulses at 1 Hz, of the test pathway.
This was followed by 60min of post-conditioning record-
ing. In some cases, slices were removed immediately after
LFS for western blotting processing.
Hippocampal slice culture and whole-cell patch recording
Hippocampal slice cultures were prepared from 6–8-
day-old male Wistar rats. Hippocampal slices (350 μm)
were cut using a McIlwain tissue chopper and cultured
on semipermeable membrane inserts (Millipore Cor-
poration, Bedford, MA, USA) in a six-well plate con-
taining culture medium (78.8% minimum essential
medium, 20% heat-inactivated horse serum, 30mM
HEPES, 26 mM D-glucose, 5.8 mM NaHCO3, 2 mM
CaCl2, 2 mM MgSO4, 70 μM ascorbic acid, 1 μg/ml
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insulin, pH adjusted to 7.3 and 320–330mOsm). Slices
were cultured for 6–8 days in vitro (DIV) with a change of
medium every 2 days, without antibiotics. Neurons were
transfected using a biolistic gene gun (Helios Gene-gun
system, Bio Rad, USA) at DIV3–4 (100 μg DNA; 90% of
the construct to test; 10% pEGFP-C1). Electro-
physiological recordings were performed 3–4 days after
transfection.
For whole-cell patch recordings, cultured slices were
perfused with a warmed (28–29 °C) recording solution
(119mM NaCl, 2.5 mM KCl, 26mM NaHCO3, 1 mM
NaH2PO4, 4 mM MgCl2, 11mM D-glucose, 4 mM CaCl2,
10 μM 2-chloroadenosine and 20 μM picrotoxin). The
recording solution was continuously bubbled with
95% O2/5% CO2 at source. The usual ﬂow rate was
2ml/min. In most recordings, two independent stimulat-
ing electrodes were placed separately in the Schaffer
collateral–CA1 input and subiculum–CA1 input.
Recordings were made from pyramidal neurons in the
CA1 region, using glass pipettes containing CsMeSO4
internal solution (as above) and neurons voltage
clamped at −70mV unless otherwise stated. To induce
LTD, a 10-min baseline was followed by 1 Hz stimulation
(200 stimuli) with recorded neurons voltage clamped
at −40mV. To induce LTP, a 5-min baseline was
followed by a 2 Hz stimulation (200 stimuli) with recorded
neurons voltage clamped at 0 mV. For quantiﬁcation
and comparisons between groups/inputs, the peak EPSC
amplitude of the test input (relative to baseline) was
averaged 15–20min (cultured slice) or 20–25min (acute
slice) after conditioning was applied. EPSCAMPA was
measured as the peak EPSC amplitude at a holding
potential of −70mV. EPSCNMDA was measured as the
peak EPSC amplitude 90–100ms after stimulus, at a
holding potential of +40mV.
Drugs and antibodies
The following drugs were dissolved in internal record-
ing solution (for postsynaptic infusion) or aCSF (for bath
perfusion) at concentrations based on previous studies:
AEBSF (20 μM45; Sigma-Aldrich, MO, USA), apocynin
(100 μM46; Abcam, Cambridge, UK), SOD (300 units/
ml47; Sigma-Aldrich, MO, USA), catalase (300 units/ml48;
Sigma-Aldrich, MO, USA), ML-171 (3 μM49; Tocris,
Oxford, UK) and AP5 (Hello Bio, Bristol, UK). Primary
antibodies used for western blotting were pT410 PKCζ
(Cell Signaling, MA, USA), total PKCζ (Santa Cruz, Texas,
USA) and total β-actin (Abcam, Cambridge, UK).
Expression/shRNA plasmids and single-cell PCR
Constructs for shRNA knockdown of target transcripts
were generated using the Block-iT™ pENTR/U6 system, as
per the manufacturer’s instructions (Life Technologies,
UK). The target sequences for rat NOX1 and NOX2 were
GCAACTGTTCATACTCTTTCC and GGTCTTACTTT
GAAGTGTTCT, respectively. NOX2 scrambled shRNA
sequence was GGTAGTTACTCGTTAGTTTCT. PKCζ
shRNA target sequence was GGCCATGAGCATCTCTG
TTGT and for p47phox it was GCTCCTACCCTGCTT
TAATGT. P47phox-rescue and mutation experiments were
performed with co-transfection of the p47phox shRNA
construct and a pCMV-SPORT6-p47phox cDNA clone
(Source Bioscience, UK). Site-directed mutagenesis to
generate S/T304/305A, S/T304/305/316A, S316A and
S329A constructs was performed on the pCMV-SPORT6-
p47phox construct using QuikChange™ technology, as per
the manufacturer’s instructions (Agilent Technologies,
USA). All generated constructs were sequence veriﬁed via
Sanger sequencing (Source Bioscience, UK).
Knockdown efﬁciencies of the generated shRNAs were
veriﬁed by neuronal single-cell PCR. Brieﬂy, transfected and
non-transfected control cells were excised from cultured
slices using low-resistance electrodes and then snap frozen.
Cells were then subjected to OneStep™ RT-PCR (Qiagen,
The Netherlands), as per the manufacturer’s instructions,
using speciﬁc exon-spanning primers: NOX1: sense 5′-AG
AGGCTCCAGACCTCCATTT-3′, anti-sense, 5′-CGT
GTGGTTGCAAAATGAGCA-3′; NOX2: sense 5′-AGCAC
TTCACACGGCCATTC-3′, anti-sense 5′-AGAGGTCAG
GGTGAAAGGGT-3′; PKCζ: sense 5′-GGACCTCTGTGA
GGAAGTGC-3′, anti-sense, 5′-GGATGCTTGGGAAAAC
GTGG-3′; PKMζ: sense 5′-CCTTCTATTAGATGCCTGC
TCTCC-3′, anti-sense 5′-TGAAGGAAGGTCTACACCAT
CGTTC-3′50; p47phox: sense 5′-CACCTTCATTCGCCAC
ATCG-3′, anti-sense 5′-ATGTCCCTTTCCTGACCAC-3′;
Cyclophilin: sense 5′-CCAAGACTGAGTGGCTGGA
T-3′, anti-sense 5′- TCCTGCTAGACTTGAAGGGGA
A-3′. Ampliﬁed PCR products were resolved on a
1% agarose/Midori Green gel and analysed under
ultraviolet light.
Statistical analyses
Sample sizes, indicated by n, are indicated in the ﬁgure
legends and represent the number of biological replicates.
For experiments in acute slices, this reﬂects the number
of individual animals from which the data were obtained.
For cultured slices, this reﬂects the number of individual
slices. Samples sizes for electrophysiology experiments
were determined through empirical evidence obtained
within our laboratory and are consistent with those
found in existing literature. Data are expressed as mean ±
standard error of the mean (SEM) and analysed using
the SigmaPlot software (Systat Software, Chicago, USA).
Signiﬁcance was set at p < 0.05 and unpaired t tests
were used to determine the statistical signiﬁcance of
effects vs. control inputs or untransfected cells, where
appropriate, and paired t tests were used to compare
to baseline values, when necessary.
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